Oral small-molecule GLP-1 receptor agonist safiglipron in early type 2 diabetes: a randomized, double-blind, placebo-controlled trial | Nature Medicine
Labels:
#health
No comments
Read More About This Article: https://ift.tt/cXCaepE
Subscribe to:
Post Comments
(
Atom
)
No comments :
Post a Comment